Skip to main content
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ARMP ISIN · US04216R1023 LEI · 549300QM1VCWH8KT0S21 US Manufacturing
Open in API
Filings indexed 1,011 across all filing types
Latest filing 2014-01-21 Capital/Financing Update
Country US United States of America
Listing US ARMP

About Armata Pharmaceuticals, Inc.

https://www.armatapharma.com/

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat the global threat of antibiotic-resistant infections. The company's core focus is on creating precisely targeted, high-purity phage-based treatments for serious bacterial infections. This approach aims to provide an effective alternative to conventional antibiotics by eliminating harmful bacteria while preserving the patient's healthy microbiome. Armata's pipeline includes product candidates targeting multi-drug resistant pathogens, supported by its in-house cGMP manufacturing facility for clinical and commercial supply.

Recent filings

Filing Released Lang Actions
FORM S-1
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the SEC, dated January 21, 2014. It is a registration statement under the Securities Act of 1933 for AmpliPhi Biosciences Corporation. The text includes detailed information about the offering, company background, risk factors, and other disclosures typical of an S-1 filing. This type of document is used for initial public offerings or other securities registrations and is not an annual report, earnings release, or other financial report. It is a capital markets filing related to the registration of securities for sale to the public. According to the provided filing categories, the closest match is Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. The document is not a report publication announcement or a regulatory filing fallback because it is the actual registration statement text, not just an announcement. Therefore, the appropriate classification is CAP with high confidence.
2014-01-21 English
Regulatory Filings 2014
Regulatory Filings
2014-01-13 English
Major Shareholding Notification 2014
Major Shareholding Notification
2014-01-03 English
Regulatory Filings 2014
Regulatory Filings
2014-01-02 English
FORM 10-12G
Regulatory Filings Classification · 95% confidence The document is a Form 10-12G registration statement filed with the U.S. Securities and Exchange Commission (SEC). It includes detailed sections such as Business, Risk Factors, Management's Discussion and Analysis of Financial Condition and Results of Operations, Properties, Security Ownership, Directors and Executive Officers, Executive Compensation, Legal Proceedings, Market Price and Dividends, Recent Sales of Unregistered Securities, Description of Securities, Indemnification, Financial Statements, and Exhibits. The document is a comprehensive registration statement for securities registration under the Securities Exchange Act of 1934, which is distinct from an annual report (10-K) or quarterly report (10-Q). It is a regulatory filing that does not fit into the other specific categories like Annual Report, Earnings Release, or Proxy Statement. Therefore, it falls under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not neatly fit into other categories.
2013-12-16 English
Regulatory Filings 2013
Regulatory Filings
2013-08-07 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.